Serum neurofilament light chain predicts disease severity in axonal variants of acute immune neuropathies: A retrospective monocentric cohort study
European Journal of Neurology · 2025
DOI: 10.1111/ene.16539 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Ali Maisam Afzali und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Technical University of Munich School of Medicine and Health, Munich, Germany. Hauptthemen laut MEDLINE: Neurofilament Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Else Kröner-Fresenius-Stiftung.
Abstract (Originalsprache)
Background and purpose The purpose was to explore the prognostic utility of neurofilament light chain (NfL) in patients with immune‐mediated polyradiculoneuropathies (IMPs).
Methods
This retrospective monocentric study analysed serum and cerebrospinal fluid samples from patients diagnosed with IMP collected prior to treatment initiation. NfL concentrations were correlated with clinical outcomes, including F score and hospitalization duration.
Results
Amongst 115 IMP patients tested, baseline cerebrospinal fluid and serum NfL (sNfL) concentrations were higher in acute inflammatory axonal polyradiculoneuropathy (AIAP) than other IMP variants. In the AIAP cohort, a positive correlation was observed between baseline sNfL concentrations, F score and hospitalization duration. Multivariate linear regression analysis further supported the predictive relationship between elevated baseline sNfL concentrations and clinical outcomes. Using receiver operating characteristic analysis, a cut‐off value for sNfL of 351 pg/mL was found to predict an F score >3 in AIAP with a sensitivity of 40% and specificity of 81.8%. AIAP patients with sNfL concentrations above this threshold required longer hospitalization (extended by 15 days).
Discussion
Our findings highlight the potential of baseline sNfL as an effective marker for distinguishing between IMP variants and predicting the prognosis of AIAP. Further validation may facilitate translation of sNfL into clinical practice, potentially identifying high‐risk patients for tailored treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Technical University of Munich School of Medicine and Health, Munich, Germany.
- Institute for Experimental Neuroimmunology, Technical University of Munich School of Medicine and Health, Munich, Germany.
- Munich Cluster for Systems Neurology, Munich, Germany.
ORCID-Profile: Ali Maisam Afzali, Bernhard Hemmer
Förderung
- Deutsche Forschungsgemeinschaft
- Else Kröner-Fresenius-Stiftung
Zitieren
APA
Afzali, A. M., Vosko, M., Reinhardt, N., Zinevych, I., Gmeiner, V., Korn, T., Gasperi, C., Berthele, A., Feneberg, E., & Hemmer, B. (2025). Serum neurofilament light chain predicts disease severity in axonal variants of acute immune neuropathies: A retrospective monocentric cohort study. European Journal of Neurology. https://doi.org/10.1111/ene.16539
Vancouver
Afzali AM, Vosko M, Reinhardt N, Zinevych I, Gmeiner V, Korn T, et al. Serum neurofilament light chain predicts disease severity in axonal variants of acute immune neuropathies: A retrospective monocentric cohort study. European Journal of Neurology. 2025. doi:10.1111/ene.16539
BibTeX
@article{Afzali2025,
author = {Afzali, Ali Maisam and Vosko, Milan and Reinhardt, Nya and Zinevych, Iaroslav and Gmeiner, Vincent and Korn, Thomas and Gasperi, Christiane and Berthele, Achim and Feneberg, Emily and Hemmer, Bernhard},
title = {Serum neurofilament light chain predicts disease severity in axonal variants of acute immune neuropathies: A retrospective monocentric cohort study},
journal = {European Journal of Neurology},
year = {2025},
doi = {10.1111/ene.16539}
}
EUVIMED